Apprentice raises $65M to streamline development of new therapies

 

Apprentice has raised a $65M funding round to make the development of new therapies more efficient by connecting distributed medical teams.  The company has raised $207M since its inception. Apprentice offers a software platform named the Tempo Manufacturing Cloud. This platform aims to help biotech companies make the process of developing therapies more efficient by enabling their distributed teams to communicate and collaborate seamlessly. The company claims that 15 of the 20 largest pharmaceutical companies in the U.S. use the platform. ICONIQ Growth led the funding round, with participation from Alkeon Capital Management and Insight Partners. The company aims to use the funding round to boost its sales and invest in marketing. Apprentice was founded in 2014.